Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 20 (1) , 51-59
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health (U01DK108306, DK061451, DK077906, U01CA200466, P30 CA016672, U01DK108300, U01CA21002002, 1U01DK108320)
This publication has 31 references indexed in Scilit:
- Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common CancersPancreas, 2013
- Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute PancreatitisGastroenterology, 2012
- An Exploratory Study of Inflammatory Cytokines as Prognostic Biomarkers in Patients With Ductal Pancreatic AdenocarcinomaPancreas, 2012
- Panhematin provides a therapeutic benefit in experimental pancreatitisGut, 2010
- Different profiles of cytokine expression during mild and severe acute pancreatitisWorld Journal of Gastroenterology, 2010
- Multicenter Approach to Recurrent Acute and Chronic Pancreatitis in the United States: The North American Pancreatitis Study 2 (NAPS2)Pancreatology, 2008
- Pancreatic Cancer–Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of CancerGastroenterology, 2008
- The pancreatic stellate cell: a star on the rise in pancreatic diseasesJournal of Clinical Investigation, 2007
- Chronic Alcohol Consumption Accelerates Fibrosis in Response to Cerulein-Induced Pancreatitis in RatsThe American Journal of Pathology, 2005
- Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-valuesBioinformatics, 2003